Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-01-07 3:41 pm Purchase | 13G | AVROBIO Inc. AVRO | JPMORGAN CHASE & CO JPM | 4,537,247 10.3% | 28,902 (+0.64%) | View |
| 2021-08-05 5:10 pm Purchase | 13G | AVROBIO Inc. AVRO | Deep Track Capital LP | 2,211,129 5.07% | 2,211,129 (New Position) | View |
| 2021-02-16 4:30 pm Sale | 13G | AVROBIO Inc. AVRO | CITADEL ADVISORS LLC | 1,668,811 4% | -20,211 (-1.20%) | View |
| 2021-02-16 4:02 pm Sale | 13D | AVROBIO Inc. AVRO | SVLSF VI LLC | 1,417,204 4.5% | -513,500 (-26.60%) | View |
| 2021-01-28 5:55 pm Purchase | 13G | AVROBIO Inc. AVRO | BlackRock Inc. BLK | 3,235,078 7.8% | 1,436,486 (+79.87%) | View |
| 2021-01-20 1:08 pm Purchase | 13G | AVROBIO Inc. AVRO | JPMORGAN CHASE & CO JPM | 4,508,345 10.8% | 681,888 (+17.82%) | View |
| 2020-11-30 10:57 am Purchase | 13G | AVROBIO Inc. AVRO | Camber Capital Management LP | 3,133,333 7.56% | 3,133,333 (New Position) | View |
| 2020-11-09 12:50 pm Purchase | 13G | AVROBIO Inc. AVRO | JPMORGAN CHASE & CO JPM | 3,826,457 10.4% | 1,677,942 (+78.10%) | View |
| 2020-02-14 4:07 pm Purchase | 13G | AVROBIO Inc. AVRO | CITADEL ADVISORS LLC | 1,689,022 5.3% | 326,367 (+23.95%) | View |
| 2020-02-14 4:03 pm Sale | 13G | AVROBIO Inc. AVRO | Cormorant Asset Management LP | 317,579 1% | -1,040,205 (-76.61%) | View |
| 2020-02-07 08:45 am Purchase | 13G | AVROBIO Inc. AVRO | BlackRock Inc. BLK | 1,798,592 5.7% | 1,798,592 (New Position) | View |
| 2020-01-22 10:09 am Purchase | 13G | AVROBIO Inc. AVRO | JPMORGAN CHASE & CO JPM | 2,148,515 6.7% | 2,148,515 (New Position) | View |
| 2019-08-05 6:52 pm Sale | 13D | AVROBIO Inc. AVRO | Clarus Lifesciences III L.P. | 0 0% | -1,481,162 (Position Closed) | View |
| 2019-07-30 5:25 pm Unchanged | 13D | AVROBIO Inc. AVRO | Atlas Venture Fund X L.P. | 4,756,478 15.1% | 0 (Unchanged) | View |
| 2019-05-22 9:13 pm Sale | 13D | AVROBIO Inc. AVRO | Clarus Lifesciences III L.P. | 1,481,162 6.1% | -1,481,163 (-50.00%) | View |